How Allergy Treatments Work to Cure Allergies Rather Than Just Masking Symptoms

Allergies affect millions of people worldwide, causing discomfort, disruption, and in severe cases, life-threatening reactions. Traditionally, many allergy treatments have focused on symptom relief—antihistamines, decongestants, and corticosteroids that offer temporary relief but do not address the underlying cause. However, advances in medical research and immunotherapy have led to treatments that aim to cure or significantly reduce allergic reactions rather than just masking symptoms. In this article, we will explore how allergy treatments work, including immunotherapy, biologics, and emerging therapies that target the root cause of allergic responses.

An allergy occurs when the immune system mistakenly identifies a harmless substance—such as pollen, pet dander, or certain foods—as a threat. This triggers an immune response, leading to the release of histamines and other chemicals that cause symptoms like sneezing, itching, swelling, and breathing difficulties. Most conventional treatments suppress these symptoms without altering the immune system’s misidentification of allergens.

Allergen immunotherapy is the most effective long-term treatment for allergies, addressing the root cause rather than simply suppressing symptoms. Immunotherapy works by gradually desensitizing the immune system to specific allergens, reducing allergic reactions over time. There are two primary forms of immunotherapy:

Allergy Shots (Subcutaneous Immunotherapy – SCIT)

Allergy shots involve injecting small, increasing doses of an allergen into the body over time. This controlled exposure helps the immune system build tolerance and reduces allergic reactions. The process involves:

• Build-up phase: Injections are given 1-2 times per week with gradually increasing doses over 3-6 months.
• Maintenance phase: Once an effective dose is reached, injections are spaced out to every 2-4 weeks for 3-5 years.
• Long-term effects: Many patients experience significant symptom reduction or even complete remission of their allergies after completing the treatment.

Sublingual Immunotherapy (SLIT)

SLIT involves placing allergen extracts under the tongue daily instead of getting injections. This method is particularly useful for patients who prefer an alternative to shots. SLIT works similarly to SCIT but requires daily administration, often in the form of tablets or liquid drops.

Both SCIT and SLIT aim to reprogram the immune system, making it less sensitive to allergens and ultimately leading to a long-term cure or significant reduction in symptoms.

Biologics are a newer class of allergy treatments that target specific components of the immune system involved in allergic reactions. These therapies are particularly beneficial for individuals with severe allergies, including asthma and chronic sinusitis. Some of the most commonly used biologics for allergies include:

Omalizumab (Xolair)

Omalizumab is a monoclonal antibody that targets immunoglobulin E (IgE), the antibody responsible for allergic reactions. By neutralizing IgE, omalizumab prevents the activation of mast cells and basophils, reducing allergic inflammation. It is primarily used for severe asthma and chronic hives but has shown promise in treating food allergies and allergic rhinitis.

Dupilumab (Dupixent)

Dupilumab blocks interleukin-4 (IL-4) and interleukin-13 (IL-13), two key cytokines involved in allergic inflammation. This biologic is approved for treating atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making it a powerful option for individuals with multiple allergic conditions.

Mepolizumab (Nucala) and Reslizumab (Cinqair)

These biologics target interleukin-5 (IL-5), a cytokine that promotes the production of eosinophils—white blood cells involved in allergic inflammation. By reducing eosinophil levels, these treatments help control severe asthma and related allergic conditions.

Scientists are continuously developing innovative therapies that may offer permanent solutions to allergies. Some of the most promising approaches include:

CRISPR and Gene Editing

Gene-editing technologies like CRISPR are being explored as a potential cure for allergies. Researchers are investigating ways to modify genes associated with the immune system’s overreaction to allergens, potentially providing a one-time cure.

Tolerance-Inducing Peptides

Scientists are developing peptides that can train the immune system to tolerate allergens without triggering a full allergic response. These treatments are in early clinical trials but show significant promise.

Microbiome-Based Therapies

The gut microbiome plays a crucial role in immune function, and imbalances in gut bacteria have been linked to increased allergy risk. Probiotic therapies and fecal microbiota transplants (FMT) are being studied as potential treatments to restore immune balance and reduce allergies.

Patients with moderate to severe allergies, particularly those whose symptoms interfere with daily life or do not respond well to traditional medications, are the best candidates for immunotherapy or biologics. Immunotherapy is most effective for:

• Seasonal allergic rhinitis (hay fever)
• Asthma triggered by allergens
• Insect sting allergies
• Pet and dust mite allergies

Biologic therapies are often reserved for patients with severe asthma, chronic sinusitis, or multiple allergic conditions that are difficult to manage with standard treatments.

While traditional allergy treatments offer quick relief, they do not address the root cause of allergic reactions. Immunotherapy, biologics, and emerging gene and microbiome-based therapies provide hope for a future where allergies can be cured or significantly reduced rather than just managed. For those suffering from allergies, consulting with an allergist about long-term treatment options may be the first step towards a life free from allergy symptoms. As research continues, the dream of a permanent allergy cure is becoming closer to reality.